FindTrial
Sign In

Study in which we have compared postoperative pain relief after applying quadratus lumborum block or transversus abdominis plane block using USG in patients undergoing abdominal hysterectomy under general anaesthesia.

Prospective randomized clinical study to assess the efficacy of ultrasound guided quadratus lumborum (QL) block versus transversus abdominis plane (TAP) block for postoperative analgesia in patients undergoing abdominal hysterectomy under general anaesthesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042468
Enrollment
70
Registered
2022-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri Health Condition 2: N72- Inflammatory disease of cervix uteri

Interventions

Intervention1: Quadratus Lumborum Block (QLB Type 3) with general anaesthesia: USG guided Quadratus Lumborum Block ( QLB TYPE 3) using ROPIVACAINE 0.375% 20 ml + 20 ml bilaterally is given between Qua

Sponsors

JLN medical college Ajmer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 18 and 60 years. Body weight 30 to 80 kg. Patients belonging to ASA (American Society of Anaesthesiologists) class 1 and 2. Patients undergoing abdominal hysterectomy of duration 1 to 2 hours in theatre with haemoglobin atleast 9 gm/dl. Patient free from any associated acute or chronic systemic illness

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study. Uncooperative patients. Patient with chronic pain or on long-term analgesics. Any known hypersensitivity or contraindication to bupivacaine. Local pathology at the site of injection or disability limiting the performance of block,(deformity of spine). Patients receiving beta blockers or cardiac drugs. History of convulsion, allergy to the drug used, bleeding disorder,severe neurological deficit, thyroid disorder. Patient with history of respiratory, cardiac, hepatic or renal disease (necessitating classification in ASA Class III or above). Patients having a history of significant neurological, psychiatric, or neuromuscular disorders. Pregnant, lactating mothers.

Design outcomes

Primary

MeasureTime frame
Comparison of Number and frequency of postoperative analgesia required in both the groups for First 24 hours Postoperatively To assess the effective analgesia by visual analog scale (VAS) scoreTimepoint: around 1 year—

Secondary

MeasureTime frame
To assess and compare the hemodynamic changes . To assess and compare the proportion of patients having adverse effects and any other complications. To acess quality of recovery.Timepoint: around 1 year—

Countries

India

Contacts

Public ContactDr Kavita Jain

Jawaharlal Nehru medical college and hospital

drkavitajain15@gmail.com9414006151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026